Global Healthcare Distribution Market

Healthcare Distribution Comprehensive Study by Type (Pharmaceutical Product Distribution Services, Medical Device Distribution Services, Biopharmaceutical Product Distribution Services, Other Products), Distribution Channel (Online, Offline), End User (Retail Pharmacies, Hospital Pharmacies, Other End Users) Players and Region - Global Market Outlook to 2030

Healthcare Distribution Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Healthcare Distribution
Healthcare distribution refers to the process that involves the storage as well as the movement of pharmaceutical product from the manufacturing plant to wholesalers or hospital/clinic. Companies dealing with the healthcare distribution comply with strict government regulations such as pharmaceutical product ought to reach patients in usable form so that they may not affect a patient’s health. Increase in chronic diseases and growth in the healthcare sector will drive the market for healthcare distribution in the forecasted period.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


Competition among existing players is due to the Healthcare Distribution market share occupied by leading players. The industry leader is engaged in offering innovative and superior quality products to cater to the ever-growing demand for Industrial lighting Market. The companies are implementing strategic activities such as acquisitions and mergers along with collaboration with companies in other industries to aid them in improving sustenance and maintaining their competitive advantage.The Players having a strong hold in the market are McKesson Corporation (US), AmerisourceBergen Corporation (US), Cardinal Health, Inc. (US), Owens & Minor, Inc. (US). Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Healthcare Distribution market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

AmerisourceBergen Corporation (United States), McKesson Corporation (United States), Cardinal Health, Inc. (United States), Morris and Dickson Co., LLC (United States), Owens & Minor, Inc. (United States), Rochester Drug Cooperative, Inc. (United States), KeySource Medical, Inc. (United States), Smith Drug Company (United States), Shanghai Pharmaceutical Group Co., Ltd. (China), PHOENIX Group (Germany), Mutual Drug (United States), Henry Schein Inc. (United States) and Patterson Companies Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are FFF Enterprises (United States), Medline Industries (United States) and CuraScript SD (United States).

Segmentation Overview
AMA Research has segmented the market of Global Healthcare Distribution market by Type (Pharmaceutical Product Distribution Services, Medical Device Distribution Services, Biopharmaceutical Product Distribution Services and Other Products) and Region.



On the basis of geography, the market of Healthcare Distribution has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. If we see Market by Distribution Channel, the sub-segment i.e. Online will boost the Healthcare Distribution market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Retail Pharmacies will boost the Healthcare Distribution market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Latest Technology Advancement and Innovation in which Suppliers are investing in Advance to Support Growth

Market Growth Drivers:
Rise in Incidence and Large Economic Burden of Chronic Diseases, Growth of Track & Trace Solutions, Growing Importance of Generics and Growth of the Medical Devices Industry

Challenges:
Price Sensitivity in the Market Due to Demand and Supply Gap

Restraints:
Stringent Government Rules and Regulations

Opportunities:
Potential Growth in Emerging Countries and Rise in Specialty Drug Dispensing

Market Leaders and their expansionary development strategies
In April 2019, Cardinal Health collaborated with PANTHERx Specialty Pharmacy (US) to strengthen its cell and gene therapy offerings with a coordinated suite of speciality distribution, third-party logistics (3PL) services, and speciality pharmacy dispensing services.
In October 2023, The Healthcare Distribution Alliance (HDA) launched a new initiative, “We Are Health Delivered,” to emphasize the pharma distribution’s industry’s commitment to delivering health to communities across America. As part of the launch, HDA is releasing a new 30-second national advertisement that spotlights the people.


Key Target Audience
Manufacturers Suppliers and Distributors, Venture Capitalists and Private Equity Firms, New Entrants/Investors, Strategic Business Planners, Government Regulatory, Research Organizations, End-Use Industries and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Pharmaceutical Product Distribution Services
  • Medical Device Distribution Services
  • Biopharmaceutical Product Distribution Services
  • Other Products
By Distribution Channel
  • Online
  • Offline

By End User
  • Retail Pharmacies
  • Hospital Pharmacies
  • Other End Users

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in Incidence and Large Economic Burden of Chronic Diseases
      • 3.2.2. Growth of Track & Trace Solutions
      • 3.2.3. Growing Importance of Generics
      • 3.2.4. Growth of the Medical Devices Industry
    • 3.3. Market Challenges
      • 3.3.1. Price Sensitivity in the Market Due to Demand and Supply Gap
    • 3.4. Market Trends
      • 3.4.1. Latest Technology Advancement and Innovation in which Suppliers are investing in Advance to Support Growth
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Healthcare Distribution, by Type, Distribution Channel, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Healthcare Distribution (Value)
      • 5.2.1. Global Healthcare Distribution by: Type (Value)
        • 5.2.1.1. Pharmaceutical Product Distribution Services
        • 5.2.1.2. Medical Device Distribution Services
        • 5.2.1.3. Biopharmaceutical Product Distribution Services
        • 5.2.1.4. Other Products
      • 5.2.2. Global Healthcare Distribution by: Distribution Channel (Value)
        • 5.2.2.1. Online
        • 5.2.2.2. Offline
      • 5.2.3. Global Healthcare Distribution by: End User (Value)
        • 5.2.3.1. Retail Pharmacies
        • 5.2.3.2. Hospital Pharmacies
        • 5.2.3.3. Other End Users
      • 5.2.4. Global Healthcare Distribution Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Healthcare Distribution: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. AmerisourceBergen Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. McKesson Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cardinal Health, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Morris and Dickson Co., LLC (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Owens & Minor, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Rochester Drug Cooperative, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. KeySource Medical, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Smith Drug Company (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Shanghai Pharmaceutical Group Co., Ltd. (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. PHOENIX Group (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Mutual Drug (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Henry Schein Inc. (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Patterson Companies Inc. (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Healthcare Distribution Sale, by Type, Distribution Channel, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Healthcare Distribution (Value)
      • 7.2.1. Global Healthcare Distribution by: Type (Value)
        • 7.2.1.1. Pharmaceutical Product Distribution Services
        • 7.2.1.2. Medical Device Distribution Services
        • 7.2.1.3. Biopharmaceutical Product Distribution Services
        • 7.2.1.4. Other Products
      • 7.2.2. Global Healthcare Distribution by: Distribution Channel (Value)
        • 7.2.2.1. Online
        • 7.2.2.2. Offline
      • 7.2.3. Global Healthcare Distribution by: End User (Value)
        • 7.2.3.1. Retail Pharmacies
        • 7.2.3.2. Hospital Pharmacies
        • 7.2.3.3. Other End Users
      • 7.2.4. Global Healthcare Distribution Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Healthcare Distribution: by Type(USD Million)
  • Table 2. Healthcare Distribution Pharmaceutical Product Distribution Services , by Region USD Million (2018-2023)
  • Table 3. Healthcare Distribution Medical Device Distribution Services , by Region USD Million (2018-2023)
  • Table 4. Healthcare Distribution Biopharmaceutical Product Distribution Services , by Region USD Million (2018-2023)
  • Table 5. Healthcare Distribution Other Products , by Region USD Million (2018-2023)
  • Table 6. Healthcare Distribution: by Distribution Channel(USD Million)
  • Table 7. Healthcare Distribution Online , by Region USD Million (2018-2023)
  • Table 8. Healthcare Distribution Offline , by Region USD Million (2018-2023)
  • Table 9. Healthcare Distribution: by End User(USD Million)
  • Table 10. Healthcare Distribution Retail Pharmacies , by Region USD Million (2018-2023)
  • Table 11. Healthcare Distribution Hospital Pharmacies , by Region USD Million (2018-2023)
  • Table 12. Healthcare Distribution Other End Users , by Region USD Million (2018-2023)
  • Table 13. South America Healthcare Distribution, by Country USD Million (2018-2023)
  • Table 14. South America Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 15. South America Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 16. South America Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 17. Brazil Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 18. Brazil Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 19. Brazil Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 20. Argentina Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 21. Argentina Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 22. Argentina Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 23. Rest of South America Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 24. Rest of South America Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 25. Rest of South America Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 26. Asia Pacific Healthcare Distribution, by Country USD Million (2018-2023)
  • Table 27. Asia Pacific Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 28. Asia Pacific Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 29. Asia Pacific Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 30. China Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 31. China Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 32. China Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 33. Japan Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 34. Japan Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 35. Japan Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 36. India Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 37. India Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 38. India Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 39. South Korea Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 40. South Korea Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 41. South Korea Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 42. Taiwan Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 43. Taiwan Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 44. Taiwan Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 45. Australia Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 46. Australia Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 47. Australia Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 51. Europe Healthcare Distribution, by Country USD Million (2018-2023)
  • Table 52. Europe Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 53. Europe Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 54. Europe Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 55. Germany Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 56. Germany Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 57. Germany Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 58. France Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 59. France Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 60. France Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 61. Italy Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 62. Italy Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 63. Italy Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 64. United Kingdom Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 65. United Kingdom Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 66. United Kingdom Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 67. Netherlands Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 68. Netherlands Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 69. Netherlands Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 70. Rest of Europe Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 71. Rest of Europe Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 72. Rest of Europe Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 73. MEA Healthcare Distribution, by Country USD Million (2018-2023)
  • Table 74. MEA Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 75. MEA Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 76. MEA Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 77. Middle East Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 78. Middle East Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 79. Middle East Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 80. Africa Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 81. Africa Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 82. Africa Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 83. North America Healthcare Distribution, by Country USD Million (2018-2023)
  • Table 84. North America Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 85. North America Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 86. North America Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 87. United States Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 88. United States Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 89. United States Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 90. Canada Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 91. Canada Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 92. Canada Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 93. Mexico Healthcare Distribution, by Type USD Million (2018-2023)
  • Table 94. Mexico Healthcare Distribution, by Distribution Channel USD Million (2018-2023)
  • Table 95. Mexico Healthcare Distribution, by End User USD Million (2018-2023)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Healthcare Distribution: by Type(USD Million)
  • Table 110. Healthcare Distribution Pharmaceutical Product Distribution Services , by Region USD Million (2025-2030)
  • Table 111. Healthcare Distribution Medical Device Distribution Services , by Region USD Million (2025-2030)
  • Table 112. Healthcare Distribution Biopharmaceutical Product Distribution Services , by Region USD Million (2025-2030)
  • Table 113. Healthcare Distribution Other Products , by Region USD Million (2025-2030)
  • Table 114. Healthcare Distribution: by Distribution Channel(USD Million)
  • Table 115. Healthcare Distribution Online , by Region USD Million (2025-2030)
  • Table 116. Healthcare Distribution Offline , by Region USD Million (2025-2030)
  • Table 117. Healthcare Distribution: by End User(USD Million)
  • Table 118. Healthcare Distribution Retail Pharmacies , by Region USD Million (2025-2030)
  • Table 119. Healthcare Distribution Hospital Pharmacies , by Region USD Million (2025-2030)
  • Table 120. Healthcare Distribution Other End Users , by Region USD Million (2025-2030)
  • Table 121. South America Healthcare Distribution, by Country USD Million (2025-2030)
  • Table 122. South America Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 123. South America Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 124. South America Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 125. Brazil Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 126. Brazil Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 127. Brazil Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 128. Argentina Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 129. Argentina Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 130. Argentina Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 131. Rest of South America Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 132. Rest of South America Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 133. Rest of South America Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 134. Asia Pacific Healthcare Distribution, by Country USD Million (2025-2030)
  • Table 135. Asia Pacific Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 136. Asia Pacific Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 137. Asia Pacific Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 138. China Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 139. China Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 140. China Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 141. Japan Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 142. Japan Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 143. Japan Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 144. India Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 145. India Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 146. India Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 147. South Korea Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 148. South Korea Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 149. South Korea Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 150. Taiwan Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 151. Taiwan Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 152. Taiwan Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 153. Australia Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 154. Australia Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 155. Australia Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 156. Rest of Asia-Pacific Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 157. Rest of Asia-Pacific Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 158. Rest of Asia-Pacific Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 159. Europe Healthcare Distribution, by Country USD Million (2025-2030)
  • Table 160. Europe Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 161. Europe Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 162. Europe Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 163. Germany Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 164. Germany Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 165. Germany Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 166. France Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 167. France Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 168. France Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 169. Italy Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 170. Italy Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 171. Italy Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 172. United Kingdom Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 173. United Kingdom Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 174. United Kingdom Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 175. Netherlands Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 176. Netherlands Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 177. Netherlands Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 178. Rest of Europe Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 179. Rest of Europe Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 180. Rest of Europe Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 181. MEA Healthcare Distribution, by Country USD Million (2025-2030)
  • Table 182. MEA Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 183. MEA Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 184. MEA Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 185. Middle East Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 186. Middle East Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 187. Middle East Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 188. Africa Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 189. Africa Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 190. Africa Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 191. North America Healthcare Distribution, by Country USD Million (2025-2030)
  • Table 192. North America Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 193. North America Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 194. North America Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 195. United States Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 196. United States Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 197. United States Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 198. Canada Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 199. Canada Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 200. Canada Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 201. Mexico Healthcare Distribution, by Type USD Million (2025-2030)
  • Table 202. Mexico Healthcare Distribution, by Distribution Channel USD Million (2025-2030)
  • Table 203. Mexico Healthcare Distribution, by End User USD Million (2025-2030)
  • Table 204. Research Programs/Design for This Report
  • Table 205. Key Data Information from Secondary Sources
  • Table 206. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Healthcare Distribution: by Type USD Million (2018-2023)
  • Figure 5. Global Healthcare Distribution: by Distribution Channel USD Million (2018-2023)
  • Figure 6. Global Healthcare Distribution: by End User USD Million (2018-2023)
  • Figure 7. South America Healthcare Distribution Share (%), by Country
  • Figure 8. Asia Pacific Healthcare Distribution Share (%), by Country
  • Figure 9. Europe Healthcare Distribution Share (%), by Country
  • Figure 10. MEA Healthcare Distribution Share (%), by Country
  • Figure 11. North America Healthcare Distribution Share (%), by Country
  • Figure 12. Global Healthcare Distribution share by Players 2023 (%)
  • Figure 13. Global Healthcare Distribution share by Players (Top 3) 2023(%)
  • Figure 14. Global Healthcare Distribution share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. AmerisourceBergen Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 17. AmerisourceBergen Corporation (United States) Revenue: by Geography 2023
  • Figure 18. McKesson Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 19. McKesson Corporation (United States) Revenue: by Geography 2023
  • Figure 20. Cardinal Health, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Cardinal Health, Inc. (United States) Revenue: by Geography 2023
  • Figure 22. Morris and Dickson Co., LLC (United States) Revenue, Net Income and Gross profit
  • Figure 23. Morris and Dickson Co., LLC (United States) Revenue: by Geography 2023
  • Figure 24. Owens & Minor, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Owens & Minor, Inc. (United States) Revenue: by Geography 2023
  • Figure 26. Rochester Drug Cooperative, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Rochester Drug Cooperative, Inc. (United States) Revenue: by Geography 2023
  • Figure 28. KeySource Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. KeySource Medical, Inc. (United States) Revenue: by Geography 2023
  • Figure 30. Smith Drug Company (United States) Revenue, Net Income and Gross profit
  • Figure 31. Smith Drug Company (United States) Revenue: by Geography 2023
  • Figure 32. Shanghai Pharmaceutical Group Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 33. Shanghai Pharmaceutical Group Co., Ltd. (China) Revenue: by Geography 2023
  • Figure 34. PHOENIX Group (Germany) Revenue, Net Income and Gross profit
  • Figure 35. PHOENIX Group (Germany) Revenue: by Geography 2023
  • Figure 36. Mutual Drug (United States) Revenue, Net Income and Gross profit
  • Figure 37. Mutual Drug (United States) Revenue: by Geography 2023
  • Figure 38. Henry Schein Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 39. Henry Schein Inc. (United States) Revenue: by Geography 2023
  • Figure 40. Patterson Companies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 41. Patterson Companies Inc. (United States) Revenue: by Geography 2023
  • Figure 42. Global Healthcare Distribution: by Type USD Million (2025-2030)
  • Figure 43. Global Healthcare Distribution: by Distribution Channel USD Million (2025-2030)
  • Figure 44. Global Healthcare Distribution: by End User USD Million (2025-2030)
  • Figure 45. South America Healthcare Distribution Share (%), by Country
  • Figure 46. Asia Pacific Healthcare Distribution Share (%), by Country
  • Figure 47. Europe Healthcare Distribution Share (%), by Country
  • Figure 48. MEA Healthcare Distribution Share (%), by Country
  • Figure 49. North America Healthcare Distribution Share (%), by Country
List of companies from research coverage that are profiled in the study
  • AmerisourceBergen Corporation (United States)
  • McKesson Corporation (United States)
  • Cardinal Health, Inc. (United States)
  • Morris and Dickson Co., LLC (United States)
  • Owens & Minor, Inc. (United States)
  • Rochester Drug Cooperative, Inc. (United States)
  • KeySource Medical, Inc. (United States)
  • Smith Drug Company (United States)
  • Shanghai Pharmaceutical Group Co., Ltd. (China)
  • PHOENIX Group (Germany)
  • Mutual Drug (United States)
  • Henry Schein Inc. (United States)
  • Patterson Companies Inc. (United States)
Additional players considered in the study are as follows:
FFF Enterprises (United States) , Medline Industries (United States) , CuraScript SD (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 142 Pages 92 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Healthcare Distribution Market Quantitative research analysis
Global Healthcare Distribution Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as AmerisourceBergen Corporation (United States), McKesson Corporation (United States), Cardinal Health, Inc. (United States), Morris and Dickson Co., LLC (United States), Owens & Minor, Inc. (United States), Rochester Drug Cooperative, Inc. (United States), KeySource Medical, Inc. (United States), Smith Drug Company (United States), Shanghai Pharmaceutical Group Co., Ltd. (China), PHOENIX Group (Germany), Mutual Drug (United States), Henry Schein Inc. (United States) and Patterson Companies Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Latest Technology Advancement and Innovation in which Suppliers are investing in Advance to Support Growth" is seen as one of major influencing trends for Healthcare Distribution Market during projected period 2023-2030.
The Healthcare Distribution market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Healthcare Distribution Market Report?

Have a Query? Click Here

Other Related Reports

Inhalable Drugs Comprehensive Study by Type (Dry Powder Formulation, Suspension Aerosol, Solution Aerosol), Application (Respiratory Disease, Non-respiratory Disease) Players and Region - Global Mark...
$ 3500
Chain Drugstores Comprehensive Study by Type (Regular Chain, Franchise Chain, Voluntary Chain), Application (B2B, B2C), Organization Size (Small & Medium Enterprises (SMEs), Large Enterprises), Distr...
$ 3350
Hypoxia Chamber Comprehensive Study by Type (84 X 35 Mm Plates, 27 X 60 Mm Plates, 12 X 100 Mm Plates, 12 X 96-Well Plates, 18 X 25 Cm2 Flasks), Application (Animal Research, Cell Research, Others) P...
$ 3500
Medical Cosmetology Product Comprehensive Study by Type (Hyaluronic Acid, Botulinum Toxin, Others), Application (Hospital, Clinic, Others) Players and Region - Global Market Outlook to 2030
$ 3500
Bio-Pharmaceuticals Logistics Comprehensive Study by Type (Cold Chain Logistics, Non-Cold Chain Logistics), Mode Of Transportation (Air Shipping, Sea Shipping, Road Shipping, Rail Shipping), Operatio...
$ 3650
Weed Delivery Comprehensive Study by Application (Commercial, Residential, Healthcare), Weed (Indica, Sativa, Hybrid, Others), Platform (App Based, Web Based), Feature (Guide to Dispensaries, Real-Ti...
$ 3800